Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms

BWJH Penninx - Neuroscience & Biobehavioral Reviews, 2017 - Elsevier
Depression's burden of disease goes beyond functioning and quality of life and extends to
somatic health. Results from longitudinal cohort studies converge in illustrating that major …

Biomarkers for depression: recent insights, current challenges and future prospects

R Strawbridge, AH Young, AJ Cleare - … disease and treatment, 2017 - Taylor & Francis
A plethora of research has implicated hundreds of putative biomarkers for depression, but
has not yet fully elucidated their roles in depressive illness or established what is abnormal …

Variations in the oral microbiome are associated with depression in young adults

B Wingfield, C Lapsley, A McDowell, G Miliotis… - Scientific reports, 2021 - nature.com
A growing body of evidence supports an important role for alterations in the brain-gut-
microbiome axis in the aetiology of depression and other psychiatric disorders. The potential …

Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines

M Bauer, E Severus, HJ Möller, AH Young… - … journal of psychiatry …, 2017 - Taylor & Francis
Objective: Major depressive disorder (MDD) is a severe mood disorder affecting individuals
of all ages and is characterised by single or recurrent major depressive episodes. Key …

Immune cell composition in unipolar depression: a comprehensive systematic review and meta-analysis

NV Sørensen, BH Frandsen, S Orlovska-Waast… - Molecular …, 2023 - nature.com
Depression has been associated with inflammatory pathophysiological mechanisms,
including alterations in amount of circulating immune cells. However, no meta-analysis …

The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients

MGM Hamed, RS Hagag - Medical hypotheses, 2020 - Elsevier
While researchers are struggling to develop a vaccine for coronavirus disease, it is important
to evolve effective therapeutic strategies to save lives. The majority of coronavirus disease …

Inflammatory mediators in mood disorders: therapeutic opportunities

ML Pfau, C Ménard, SJ Russo - Annual Review of …, 2018 - annualreviews.org
Mood disorders such as depression are among the most prevalent psychiatric disorders in
the United States, but they are inadequately treated in a substantial proportion of patients …

[HTML][HTML] Interaction of neurotransmitters and neurochemicals with lymphocytes

D Kerage, EK Sloan, SR Mattarollo… - Journal of …, 2019 - Elsevier
Neurotransmitters and neurochemicals can act on lymphocytes by binding to receptors
expressed by lymphocytes. This review describes lymphocyte expression of receptors for a …

Neuroinflammation in major depressive disorder: a review of PET imaging studies examining the 18-kDa translocator protein

D Gritti, G Delvecchio, A Ferro, C Bressi… - Journal of affective …, 2021 - Elsevier
Abstract Background Major Depressive Disorder (MDD) is a severe psychiatric disorder
whose pathological mechanisms are largely unknown. In the field of immuno-psychiatry …

No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: a 6-week double-blind placebo controlled randomized trial

BT Baune, E Sampson, J Louise, H Hori… - European …, 2021 - Elsevier
Given the role of low-grade inflammation in the pathophysiology of major depressive
disorder (MDD), anti-inflammatory strategies may improve treatment outcomes in some …